-
PROVIDERS
Register now
Are you getting the full picture? A webinar series on the power of comprehensive intelligent diagnostics
-
LIFE SCIENCES
Enroll now
Tempus’ Patient-Derived Organoid ScreensEvaluate the efficacy of your preclinical compounds using fixed organoid panels designed for diverse therapeutic applications. Space is limited — enroll by June 30, 2025, to secure your spot.
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Increasing PTS using multimodal data
Learn how AstraZeneca employs multimodal data to increase the probability of technical success of all Phase 3 oncology studies.
-
04/02/2025Development of a clinical algorithm to prognosticate response to immunotherapy
Discover how Tempus developed and deployed the Immune Profile Score (IPS)—a powerful algorithm that provides prognostic insights into patient outcomes following treatment with immune checkpoint inhibitors (ICIs)—in ~18 months. This case study highlights the AI-driven methodology, real-world validation, and the impact of IPS in precision oncology.
Read more -
03/25/2025AI & ML in action: Unlocking RWD with GenAI through Tempus Lens
Discover how Tempus is equipping researchers with innovative AI solutions to fully leverage the potential of multimodal data. Gain insights from a panel of leaders across healthcare and life sciences as they discuss the impact of these advanced tools on delivering insights with speed.
Watch replay
Secure your recording now. -
03/11/2025Case Report: Pharmacogenomic testing and mood stabilizers
This real-world case demonstrates how the Tempus nP pharmacogenomic test facilitated a personalized treatment approach for a patient with bipolar disorder.
Read more